Aubrey Capital Management Ltd Has $5.41 Million Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Aubrey Capital Management Ltd reduced its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 38.9% during the 4th quarter, Holdings Channel reports. The fund owned 9,100 shares of the biotechnology company’s stock after selling 5,800 shares during the quarter. Axon Enterprise comprises 2.0% of Aubrey Capital Management Ltd’s portfolio, making the stock its 10th largest holding. Aubrey Capital Management Ltd’s holdings in Axon Enterprise were worth $5,407,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently added to or reduced their stakes in the company. Prestige Wealth Management Group LLC increased its position in Axon Enterprise by 115.8% in the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock valued at $33,000 after acquiring an additional 44 shares during the period. New Wave Wealth Advisors LLC acquired a new position in shares of Axon Enterprise during the 4th quarter valued at $40,000. Brooklyn Investment Group acquired a new position in shares of Axon Enterprise during the 3rd quarter valued at $41,000. Y.D. More Investments Ltd acquired a new position in shares of Axon Enterprise during the 4th quarter valued at $45,000. Finally, Planning Capital Management Corp increased its position in shares of Axon Enterprise by 83.3% during the 3rd quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock valued at $48,000 after purchasing an additional 55 shares during the period. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Axon Enterprise Stock Performance

Shares of Axon Enterprise stock opened at $679.24 on Monday. The stock has a market cap of $51.79 billion, a PE ratio of 175.51, a price-to-earnings-growth ratio of 6.79 and a beta of 1.05. The business has a fifty day simple moving average of $623.43 and a 200-day simple moving average of $496.32. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 12 month low of $255.68 and a 12 month high of $698.67.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on the company. The Goldman Sachs Group lifted their price target on Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research report on Monday, January 27th. Robert W. Baird lifted their price target on Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. TD Cowen assumed coverage on Axon Enterprise in a research report on Wednesday, January 8th. They set a “buy” rating and a $700.00 price target on the stock. Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and raised their price objective for the stock from $500.00 to $700.00 in a research note on Tuesday, December 3rd. Finally, JMP Securities raised their price objective on Axon Enterprise from $610.00 to $725.00 and gave the stock a “market outperform” rating in a research note on Tuesday, February 4th. One research analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $542.15.

Insider Transactions at Axon Enterprise

In related news, President Joshua Isner sold 20,000 shares of the stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $606.15, for a total transaction of $12,123,000.00. Following the completion of the sale, the president now directly owns 208,166 shares in the company, valued at approximately $126,179,820.90. This trade represents a 8.77 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Jeffrey C. Kunins sold 21,834 shares of the stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $593.88, for a total value of $12,966,775.92. Following the sale, the insider now owns 154,394 shares of the company’s stock, valued at approximately $91,691,508.72. This represents a 12.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 50,545 shares of company stock valued at $30,721,337 over the last quarter. Company insiders own 6.10% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.